The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, B. D.
Right arrow Articles by Wolinsky, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, B. D.
Right arrow Articles by Wolinsky, S.
The Journal of Immunology, 2003, 171: 5372-5379.
Copyright © 2003 by The American Association of Immunologists

Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses 1

Beth D. Jamieson2,*, Otto O. Yang*, Lance Hultin*, Mary Ann Hausner*, Patricia Hultin*, Jose Matud*, Kevin Kunstman{dagger}, Scott Killian*, John Altman{ddagger}, Kristina Kommander§, Bette Korber§, Janis Giorgi3,* and Steven Wolinsky{dagger}

* Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; {dagger} Division of Infectious Diseases, Department of Medicine, Northwestern University Medical School, Chicago, IL 60611; {ddagger} Emory University, Atlanta, GA 30329; and § Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545

To investigate possible mechanisms behind HIV-1 escape from CTL, we performed detailed longitudinal analysis of Gag (SLYNTVATL)- and RT (ILKEPVHGV)-specific CTL responses and plasma epitope sequences in five individuals. Among those with CTL against consensus epitope sequences, epitope mutations developed over several years, invariably followed by decay of the CTL targeting the consensus epitopes. The maturation state of the CTL varied among individuals and appeared to affect the rate of epitope mutation and CTL decay, despite similar IFN-{gamma} production. Escape mutations were oligoclonal, suggesting fitness constraints. The timing of escape indicated that the net selective advantage of escape mutants was slight, further underscoring the importance of understanding factors determining selective pressure and viral fitness in vivo. Our data show surprisingly consistent decay of CTL responses after epitope escape mutation and provide insight into potential mechanisms for both immune failure and shifting CTL specificities.




This article has been cited by other articles:


Home page
J. Virol.Home page
W. D. Wick, P. B. Gilbert, and O. O. Yang
Predicting the Impact of Blocking Human Immunodeficiency Virus Type 1 Nef In Vivo
J. Virol., March 1, 2009; 83(5): 2349 - 2356.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Lichterfeld, D. Mou, T. D. H. Cung, K. L. Williams, M. T. Waring, J. Huang, F. Pereyra, A. Trocha, G. J. Freeman, E. S. Rosenberg, et al.
Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors
Blood, November 1, 2008; 112(9): 3679 - 3687.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Balamurugan, M. J. Lewis, C. M. R. Kitchen, M. N. Robertson, J. W. Shiver, E. S. Daar, J. Pitt, A. Ali, H. L. Ng, J. S. Currier, et al.
Primary Human Immunodeficiency Virus Type 1 (HIV-1) Infection during HIV-1 Gag Vaccination
J. Virol., March 15, 2008; 82(6): 2784 - 2791.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Liu, J. McNevin, H. Zhao, D. M. Tebit, R. M. Troyer, M. McSweyn, A. K. Ghosh, D. Shriner, E. J. Arts, M. J. McElrath, et al.
Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape
J. Virol., November 15, 2007; 81(22): 12179 - 12188.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. Karlsson, J. M. Chapman, B. D. Heiken, R. Hoh, E. G. Kallas, J. N. Martin, F. M. Hecht, S. G. Deeks, and D. F. Nixon
Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol
J. Virol., October 15, 2007; 81(20): 11543 - 11548.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Shin, S. D. Blackburn, J. N. Blattman, and E. J. Wherry
Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection
J. Exp. Med., April 16, 2007; 204(4): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kan-Mitchell, M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley, T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo Jr., et al.
Degeneracy and Repertoire of the Human HIV-1 Gag p1777-85 CTL Response.
J. Immunol., June 1, 2006; 176(11): 6690 - 6701.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Draenert, T. M. Allen, Y. Liu, T. Wrin, C. Chappey, C. L. Verrill, G. Sirera, R. L. Eldridge, M. P. Lahaie, L. Ruiz, et al.
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus
J. Exp. Med., March 20, 2006; 203(3): 529 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al.
Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution
J. Virol., November 1, 2005; 79(21): 13239 - 13249.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Koibuchi, T. M. Allen, M. Lichterfeld, S. K. Mui, K. M. O'Sullivan, A. Trocha, S. A. Kalams, R. P. Johnson, and B. D. Walker
Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection
J. Virol., July 1, 2005; 79(13): 8171 - 8181.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. J. Ibarrondo, P. A. Anton, M. Fuerst, H. L. Ng, J. T. Wong, J. Matud, J. Elliott, R. Shih, M. A. Hausner, C. Price, et al.
Parallel Human Immunodeficiency Virus Type 1-Specific CD8+ T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection
J. Virol., April 1, 2005; 79(7): 4289 - 4297.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. O. Yang, E. S. Daar, B. D. Jamieson, A. Balamurugan, D. M. Smith, J. A. Pitt, C. J. Petropoulos, D. D. Richman, S. J. Little, and A. J. L. Brown
Human Immunodeficiency Virus Type 1 Clade B Superinfection: Evidence for Differential Immune Containment of Distinct Clade B Strains
J. Virol., January 15, 2005; 79(2): 860 - 868.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.